Want to see CL full AI Analyst Report?
Operating Income by Segment
Reveals profitability across different business segments, highlighting which areas are driving earnings and which may need strategic adjustments.Oral, Personal & Home Care delivers steady, resilient operating income and Pet Nutrition has shown clear acceleration (Hill’s‑led) since 2024, while Corporate is highly volatile—large one‑offs obscure core profitability. Management warns roughly $300M of incremental commodity/logistics headwinds, tariff pressure in North America, and a temporary private‑label pet exit that will weigh near‑term margins, but expanded SGPP savings and pricing/innovation should help restore operating leverage into 2027–28.
Date | Corporate | Oral, Personal, and Home Care | Pet Nutrition |
|---|---|---|---|
Jun 30, 2026 | -$181.00M | $997.00M | $264.00M |
Mar 31, 2026 | -$346.00M | $1.03B | $280.00M |
Dec 31, 2025 | -$1.19B | $999.00M | $286.00M |
Sep 30, 2025 | -$189.00M | $992.00M | $255.00M |
Jun 30, 2025 | -$181.00M | $997.00M | $264.00M |
Mar 31, 2025 | -$153.00M | $971.00M | $258.00M |
Dec 31, 2024 | -$179.00M | $969.00M | $275.00M |
Sep 30, 2024 | -$208.00M | $1.02B | $258.00M |
Jun 30, 2024 | -$201.00M | $1.06B | $235.00M |
Mar 31, 2024 | -$196.00M | $1.04B | $199.00M |